29
Views
30
CrossRef citations to date
0
Altmetric
Original Articles

Insulin analogues

New agents for improving glycemic control

, PharmD, , RPh, CDE & , MD
Pages 58-70 | Published online: 30 Jun 2015

References

  • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329(14):977–86
  • Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18(2):258–68
  • Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28(2):103–17
  • Bliss M. The discovery of insulin. Chicago: University of Chicago Press, 1982
  • Galloway JA, Chance RE. Improving insulin therapy: achievements and challenges. Horm Metab Res 1994; 26(12):591–8
  • White J, Campbell RK. Diabetes mellitus. In: Herfindal ET, Gourley DR, eds. Textbook of therapeutics: drug and disease management. 6th ed. Baltimore: Williams & Wilkins, 1996:357–86
  • Santiago J, ed. Medical management of insulin-dependent (type I) diabetes. 2d ed. New York: American Diabetes Assoc, 1994:35–7
  • Brange J, Owens DR, Kang S, et al. Monomeric insulins and their experimental and clinical implications. Diabetes Care 1990; 13(9):923–54
  • Galloway JA, Chance RE. Approaches to insulin analogues. Diabetes Annual/8 1994:277–97
  • Drejer K. The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake. Diabetes Metab Rev 1992; 8(3):259–85
  • DiMarchi RD, Chance RE, Long HB, et al. Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I. Horm Res 1994; 41(Suppl 2):93–6
  • Campbell RK, Campbell LK, White JR. Insulin lispro: review of its role in the treatment of diabetes mellitus. Ann Pharmacother 1996; 30(11):1263–71
  • Seigler DE, Olsson GM, Agramonte RF, et al. Pharmacokinetics of long-acting (ultralente) insulin preparations. Diab Nutr Metab 1991; 4:267–73
  • Jorgensen S, Vaag A, Langkjaer L, et al. NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue. BMJ 1989; 299(6696):415–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.